Sign In
Buy LLY
$1,185.71
-7.09 (-0.594%)
At Close: Aug 07, 2026
Eli Lilly CEO David Ricks on $.5.3 billion weight loss drug investment
08:49pm, Friday, 24'th May 2024
Hosted by Brian Sullivan, “Last Call” is a fast-paced, entertaining business show that explores the intersection of money, culture and policy. Tune in Monday through Friday at 7 p.m.
Lilly to Invest $5.3 Billion for Weight-Loss Drug Supply
10:40am, Friday, 24'th May 2024
Eli Lilly & Co.��will spend $5.3 billion to boost production of a key ingredient in its weight-loss and diabetes shots after the treatments' explosive popularity led to shortages. Simone Foxman re
Eli Lilly to spend $5.3 billion to boost Zepbound, Mounjaro manufacturing
10:33am, Friday, 24'th May 2024
Eli Lilly & Co. said Friday that it has more than doubled its investment in a Lebanon, Ind., site to boost manufacturing capacity for its popular weight-loss drug Zepbound and diabetes treatment Mounj
Lilly invests further $5.3 bln in new Indiana site as obesity drug demand soars
09:35am, Friday, 24'th May 2024
Eli Lilly said on Friday it has invested another $5.3 billion in its new Lebanon, Indiana manufacturing plant, more than doubling its previous investment, as it scrambles to meet soaring demand for it
Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply
09:30am, Friday, 24'th May 2024
Eli Lilly said it is investing another $5.3 billion in a manufacturing plant in Lebanon, Indiana to expand the supply of its highly popular weight loss drug Zepbound, diabetes treatment Mounjaro and o
Largest investment in active pharmaceutical ingredient manufacturing of synthetic medicines in U.S. history Since 2020, the company has committed more than $18 billion to build, upgrade and acquire fa
Ozempic cuts kidney-disease risks, research finds
09:27am, Friday, 24'th May 2024
Novo Nordisk's diabetes drug Ozempic reduces the risk of kidney failure and death in patients who have both Type 2 diabetes and chronic kidney disease, according to new research published Friday in th
Eli Lilly to Spend $5.3 Billion to Make More Mounjaro, Zepbound
09:15am, Friday, 24'th May 2024
The outlay to expand an Indiana production site, combined with a previous $3.7 billion commitment, is the largest manufacturing investment in company history.
7 Stocks to Buy if the Market Ends Up Plunging
06:00am, Friday, 24'th May 2024
Stocks to buy if the market fails: that's the other side of the coin to the search query, is the market overvalued right now? Pop that question into your favorite search engine and you're bound to fin
Lilly Announces Details of Presentations at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
05:00pm, Thursday, 23'rd May 2024
INDIANAPOLIS , May 23, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that data from studies of Verzenio® (abemaciclib; a CDK4/6 inhibitor), Retevmo® (selpercatinib; a rearra
3 Biotech Stocks to Buy on the Dip: May 2024
02:01pm, Thursday, 23'rd May 2024
Biotech is one of the most exciting industries to invest in right now. Companies have drugs on the market worth billions and continue to strive to produce the newest and best treatments in modern medi
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
11:54am, Thursday, 23'rd May 2024
Targeted radiopharmaceuticals has caught the eye of big pharma. The therapy delivers radiation directly into tumors by attaching a radioactive particle to a targeting molecule.
3 Blue Chip Stocks That You Can Buy and Hold for Years
08:05am, Thursday, 23'rd May 2024
Walmart is a retail beast with an appetite for growth, which makes it likely this company won't just stand pat in the future. Apple's business showed signs of slowing last quarter, but artificial inte
Surprise: Eli Lilly Is Racing Toward Yet Another Blockbuster
06:45am, Thursday, 23'rd May 2024
Eli Lilly's once-weekly insulin product just aced phase 3 studies. The company will battle its eternal rival, Novo Nordisk, in this market.
Lilly (LLY) Hits Record High on Crohn's Disease Study Data
02:21pm, Wednesday, 22'nd May 2024
Eli Lilly's (LLY) stock hits an all-time high after announcing detailed results from a late-stage study on mirikizumab in Crohn's disease.
